Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats

被引:36
作者
Cauli, Omar [1 ]
Mlili, Nisrin [1 ]
Llansola, Marta [1 ]
Felipo, Vicente [1 ]
机构
[1] Ctr Invest Principe Felipe, Neurobiol Lab, Valencia, Spain
关键词
hepatic encephalopathy; metabotropic glutamate receptors; motor function; neuronal circuits;
D O I
10.1111/j.1460-9568.2007.05435.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mechanisms by which liver failure alters motor function remain unclear. It has been suggested that liver disease alters the neuronal circuit between basal ganglia and cortex that modulates motor function. Activation of group I metabotropic glutamate receptors in the nucleus accumbens (NAcc) by injecting (S)-3,5-dihydroxyphenylglycine (DHPG) activates this circuit and induces locomotion We analysed by in vivo brain microdialysis the function of the circuits that modulate motor function in rats with liver failure due to portacaval shunt (PCS). We inserted cannulae in the NAcc and microdialysis probes in the NAcc, ventral pallidum (VP), substantia nigra pars reticulata (SNr), medio-dorsal thalamus (MDT), ventro-medial thalamus (VMT) or prefrontal cortex (PFCx). We injected DHPG in the NAcc and analysed extracellular neurotransmitters concentration in these areas. The results indicate that in control rats DHPG induces locomotion by activating the 'normal' neuronal circuit: NAcc -> VP -> MDT -> PFCx. In PCS rats this circuit is not activated. In PCS rats, DHPG injection activates an 'alternative' circuit: NAcc -> SNr -> VMT -> PFCx. This circuit is not activated in control rats. DHPG injection increases dopamine in the NAcc of control but not of PCS rats, and glutamate in PCS but not in control rats. DHPG-induced increase in dopamine would activate the 'normal' neuronal circuit, while an increase in glutamate would activate the 'alternative' circuit. The identification of the mechanisms responsible for altered motor function and coordination in liver disease would allow designing treatments to improve motor function in patients with hepatic encephalopathy.
引用
收藏
页码:2112 / 2122
页数:11
相关论文
共 59 条
[1]   EXCITATORY AMINO-ACID BINDING-SITES IN THE BASAL GANGLIA OF THE RAT - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
ALBIN, RL ;
MAKOWIEC, RL ;
HOLLINGSWORTH, ZR ;
DURE, LS ;
PENNEY, JB ;
YOUNG, AB .
NEUROSCIENCE, 1992, 46 (01) :35-48
[2]   Characteristics of minimal hepatic encephalopathy [J].
Amodio, P ;
Montagnese, S ;
Gatta, A ;
Morgan, MY .
METABOLIC BRAIN DISEASE, 2004, 19 (3-4) :253-267
[3]   Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat [J].
Attarian, S ;
Amalric, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (04) :809-816
[4]   PORTACAVAL-SHUNT IN THE RAT - SELECTIVE ALTERATIONS IN BEHAVIOR AND BRAIN-SEROTONIN [J].
BENGTSSON, F ;
NOBIN, A ;
FALCK, B ;
GAGE, FH ;
JEPPSSON, B .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (06) :1611-1616
[5]   BRAIN BIOPTERIN METABOLISM IN CHRONIC EXPERIMENTAL HEPATIC-ENCEPHALOPATHY [J].
BERGQVIST, PBF ;
WERNER, ER ;
APELQVIST, G ;
BUGGE, M ;
WACHTER, H ;
BENGTSSON, F .
METABOLIC BRAIN DISEASE, 1995, 10 (02) :143-157
[6]   An axotomy model for the induction of death of rat and mouse corticospinal neurons in vivo [J].
Bonatz, H ;
Röhrig, S ;
Mestres, P ;
Meyer, M ;
Giehl, KM .
JOURNAL OF NEUROSCIENCE METHODS, 2000, 100 (1-2) :105-115
[7]  
Bubser M, 1998, SYNAPSE, V30, P156, DOI 10.1002/(SICI)1098-2396(199810)30:2<156::AID-SYN5>3.0.CO
[8]  
2-B
[9]   Chronic Parkinsonism associated with cirrhosis - A distinct subset of acquired hepatocerebral degeneration [J].
Burkhard, PR ;
Delavelle, J ;
Du Pasquier, R ;
Spahr, L .
ARCHIVES OF NEUROLOGY, 2003, 60 (04) :521-528
[10]   Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo [J].
Canales, JJ ;
Elayadi, A ;
Errami, M ;
Llansola, M ;
Cauli, O ;
Felipo, V .
NEUROBIOLOGY OF DISEASE, 2003, 14 (03) :380-390